Moderna, Inc. (NASDAQ:MRNA – Get Free Report) Director Noubar Afeyan sold 15,000 shares of the business’s stock in a transaction dated Wednesday, June 5th. The stock was sold at an average price of $151.25, for a total value of $2,268,750.00. Following the transaction, the director now directly owns 1,946,931 shares of the company’s stock, valued […]